566 Staphylococcus epidermidis for the topical treatment of epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity
Mootien S, Leger R, Whitfill T. 566 Staphylococcus epidermidis for the topical treatment of epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity. Journal Of Investigative Dermatology 2024, 144: s99. DOI: 10.1016/j.jid.2024.06.582.Peer-Reviewed Original Research